The present disclosure provides a method for enhancing or inducing an immune response and/or for inducing lysis of cancer cells and/or for treating cancer in a subject, the method comprising administering to the subject a compound that neutralizes BTN2A1 and/or that binds to BTN2A1 on the cells and induces death of the cells.
申请公布号
AU2014354587(A1)
申请公布日期
2016.06.02
申请号
AU20140354587
申请日期
2014.11.28
申请人
CSL LIMITED;LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
发明人
BEHREN, ANDREAS;CEBON, JONATHAN;HUDSON, CHRISTOPHER;WOODS, KATHERINE;HAMMET, ANDREW;VERHAGEN, ANNE;MARASKOVSKY, EUGENE;PANOUSIS, CON
